| Arlene Joyce Goldman, MS, CCC-SLP | |
|
19190 Olney Mill Rd, Olney, MD 20832-1260 | |
| (240) 740-3400 | |
| (301) 570-2886 |
| Full Name | Arlene Joyce Goldman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 19190 Olney Mill Rd, Olney, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295204311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 01315 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arlene Joyce Goldman, MS, CCC-SLP 19190 Olney Mill Rd, Olney, MD 20832-1260 Ph: (240) 740-3400 | Arlene Joyce Goldman, MS, CCC-SLP 19190 Olney Mill Rd, Olney, MD 20832-1260 Ph: (240) 740-3400 |
News Archive
New research, led by psychologists at the University of Bristol, has found that children who are familiar with a snack food will expect it to be more filling.
Many studies on the containment of the ongoing COVID-19 pandemic have dealt with the possible role of wastewater in predicting and detecting future outbreaks and understanding the epidemiology of COVID-19 disease. A recent study published on the preprint server medRxiv* in September 2020 shows that solid waste in sewage is a better substrate for testing than influent.
A group of researchers of the Imperial College of London headed by Professor Isaac Marks has published a randomized controlled study on internet-guided self-help for phobias and panic in the May-June issue of Psychotherapy and Psychosomatics.
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
According to Millennium Research Group, the global authority on medical technology market intelligence, the prosperity of the US market for orthopedic extremity devices will be bolstered by continued product innovation and surgeon specialization. Despite sluggish economic performance in the US market and impending regulatory changes imposed by health care reform, the US orthopedic extremity device market will generate over $4.6 billion in revenues by 2015, growing at a compound annual growth rate in excess of 10%.
› Verified 4 days ago
Erin Marie Welch, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19190 Olney Mill Rd, Olney, MD 20832 Phone: 240-740-3400 | |
Mrs. Ilona Benderson, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3407 Olanwood Drive, Olney, MD 20832 Phone: 410-802-4985 | |
Ms. Deborah Betts, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17904 Georgia Ave, Suite 105a, Olney, MD 20832 Phone: 301-924-3021 | |
Ashley Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3401 Queen Mary Dr, Olney, MD 20832 Phone: 301-924-3126 | |
Ms. Lisa Ann Mccoy, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19528 Olney Mill Rd, Olney, MD 20832 Phone: 301-924-3140 | |
Ranell Lewis, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19190 Olney Mill Rd, Olney, MD 20832 Phone: 240-740-3400 | |
Courteney Ellerbe, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19190 Olney Mill Rd, Olney, MD 20832 Phone: 240-740-3400 |